Is Teriparatide legal in the US?
Yes, FDA approved for osteoporosis in women after menopause and in men at high risk of breaks.
Teriparatide is approved by the FDA as Forteo (and as generic and follow-on products) to treat osteoporosis in postmenopausal women and men at high risk of fracture, and glucocorticoid-induced osteoporosis. Approved in 2002; the boxed warning about osteosarcoma and the two-year lifetime limit were removed from the label in November 2020. 2
Yes, since 2002, as Forteo and later as generic and follow-on teriparatide products. The approved uses are osteoporosis in postmenopausal women and men at high risk of fracture, and osteoporosis caused by long-term steroid treatment. 2
Read the full Teriparatide page
More on Teriparatide
Citations
- Neer 2001, NEJM: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis doi.org
- Eli Lilly: Forteo (teriparatide injection) prescribing information uspl.lilly.com
Reference information only, not medical advice. Drawn from the Teriparatide article, fact-checked against the cited sources. No dosing anywhere on this site.